Search This Blog

Tuesday, February 2, 2021

Cassava Simufilam Improves Cognition, Behavior in Alzheimer’s Interim Analysis

  Patients’ Cognition Improved 1.6 Points on ADAS-Cog11 -


- Patients’ Behavior Improved 1.3 Points on NPI -

- Improvements Maintained at 6 Months -

- Results Support Advancing Simufilam into Phase 3 Clinical Program -

https://finance.yahoo.com/news/cassava-sciences-simufilam-improves-cognition-133000630.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.